Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors from the Natural Origin: A Recent Perspective

Author(s): Harun M. Patel, Rajesh Rane, Neeta Thapliyal, Mahesh Palkar, Mahamadhanif Shaikh, Rajshekhar Karpoormath

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 15 , Issue 8 , 2015

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Overexpression of epidermal growth factor receptor (EGFR) is seen in a number of human tumors like prostate, colon, breast and ovarian. Their expression is correlated with vascularity and often difficult to diagnose. Though a number of active inhibitors and anticancer drugs against EGFR-tyrosine kinase are known, increase in resistance together with many side effects designate the need for new and improved treatments. Natural products and their analoges have significant contribution in the cancer drug discovery and development process. Therefore in the current review we mainly discuss design, synthesis and structural activity relationship of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors from the natural origin.

Keywords: Epidermal growth factor receptor, Natural origin, SAR.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 16 August, 2015
Page: [988 - 1011]
Pages: 24
DOI: 10.2174/1871520615666150312100259
Price: $65

Article Metrics

PDF: 40